Authors
Xiaoyu Xu, Mengting Wang, Hao Wang, Jiayu Yu, Yanxin Huang, Li Wu, Ying Jiang, Shaorong Gao, Zhiyong Mao, Jiayu Chen, Yu Chen
Published in
Advanced science (Weinheim, Baden-Wurttemberg, Germany). Nov 18, 2026. Epub Nov 18, 2026.
Abstract
Induced pluripotent stem cell (iPSC)-based regenerative medicine holds great promise for the treatment of age-related diseases. However, it still faces numerous challenges. One critical issue is whether iPSCs, which are commonly believed to be ageless and to indefinitely self-renew in an undifferentiated state, undergo a decline in cell quality during continuous passaging, ultimately compromising their therapeutic potential. Here, we show that long-term cultured iPSCs acquire aging-like molecular and functional deterioration, including impaired DNA repair via non-homologous end joining (NHEJ), loss of cellular identity, and diminished differentiation potential. Mechanistically, decreased levels of Lamin A trigger DNA-PKcs inactivation, leading to impaired NHEJ during prolonged culture. This DNA-PKcs inactivation then suppresses DNMT3A expression via SP1/3 and induces transcriptomic signatures characteristic of aging, ultimately impairing pluripotency. Our findings establish that iPSCs undergo aging-like deterioration during extended culture through DNA damage-epigenetics crosstalk, highlighting the critical need for genomic stability monitoring. Furthermore, we identify feasible targets to improve cell quality in iPSC-based clinical applications.
PMID:
43052002
Bibliographic data and abstract were imported from PubMed on 19 Nov 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 6
- Comments 0